Personalized Cancer Treatment Gains Momentum in the Cancer/Tumor Profiling Market
The global cancer/tumor profiling market is expected to grow significantly, reaching a projected value of USD 26.29 billion by 2033 from USD 12.47 billion in 2024. The market is primarily driven by advancements in precision medicine, the increasing adoption of personalized treatment strate
